GIORGI, CARLO ALBERTO

GIORGI, CARLO ALBERTO  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
351Cannabinoids-induced toxic myocarditis underlying apical ballooning syndrome: a case proven by combined cardiac magnetic resonance and endomyocardial biopsy 2019 Carrer, ACipriani, ARizzo, SGiorgi, BCacciavillani, LTarantini, GBasso, CIliceto, SPerazzolo Marra, M + EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING - -
529Relationship between ventricular mechanics and fibro-fatty replacement on cardiac magnetic resonance in arrhythmogenic cardiomyopathy 2019 Perazzolo Marra, MBariani, RCipriani, ARizzon, GGiorgi, BQuaia, EBasso, CCorrado, DRigato, IBauce, BTona, FIliceto, S + EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING - -
Androgen receptor expression and association with distant disease-free survival in triple negative breast cancer: Analysis of 263 patients treated with standard therapy for stage I-III disease 2019 Dieci M. V.TSVETKOVA, VASSILENAGriguolo G.Miglietta F.MANTIERO, MARACumerlato E.Giorgi C. A.Giarratano T.FAGGIONI, GIULIA MARTINAVernaci G.Menichetti A.MIORANZA, ELEONORAFREZZINI, SIMONAOrvieto E.Guarneri V. + FRONTIERS IN ONCOLOGY - -
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 2015 TRIMARCO, VALENTINAAVE, ELISAFACCO, MONICACHIODIN, GIORGIAFREZZATO, FEDERICAMARTINI, VERONICAGATTAZZO, CRISTINALESSI, FEDERICAGIORGI, CARLO ALBERTOVISENTIN, ANDREACASTELLI, MONICASEVERIN, FILIPPOZAMBELLO, RENATOPIAZZA, FRANCESCOSEMENZATO, GIANPIETRO CARLOTRENTIN, LIVIO ONCOTARGET - -
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial 2022 Guarneri, ValentinaDieci, Maria VittoriaGriguolo, GaiaMiglietta, FedericaBottosso, MicheleGiorgi, Carlo AlbertoConte, PierFranco + EBIOMEDICINE - -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 2021 Giorgi C. A.Griguolo G.Guarneri V. + CLINICAL CANCER RESEARCH - -
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 2021 Dieci M. V.Griguolo G.Bottosso M.Tsvetkova V.Giorgi C. A.Vernaci G.Tasca G.Genovesi E.Cumerlato E.Conte P. F.Guarneri V. + NPJ BREAST CANCER - -
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation 2022 Dieci, Maria VittoriaMiglietta, FedericaGiorgi, Carlo AlbertoCumerlato, EnricoAmato, OttaviaMassa, DavideGriguolo, GaiaGenovesi, ElisaFassan, MatteoZarrilli, GiovanniGuarneri, Valentina + BRITISH JOURNAL OF CANCER - -
Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy 2020 Dieci M. V.Tsvetkova V.Griguolo G.Miglietta F.Tasca G.Giorgi C. A.Cumerlato E.Massa D.Orvieto E.Guarneri V.Conte P. + EUROPEAN JOURNAL OF CANCER - -
P1596Tissue characterization in Arrhythmogenic Cardiomyopathy: diagnostic impact of combined endomyocardial biopsy and cardiac magnetic resonance approach 2017 Rizzo, S.De Lazzari, M.Cipriani, A.Rigato, I.Tarantini, G.Pilichou, K.Giorgi, B.Corrado, D.Bauce, B.Iliceto, S.Thiene, G.Basso, C.Perazzolo Marra, M. + EUROPEAN HEART JOURNAL - -
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 2020 Di Liso, ElisabettaBottosso, MicheleTsvetkova, VassilenaDieci, Maria VittoriaMiglietta, FedericaTasca, GiuliaGiorgi, Carlo AlbertoGiarratano, TommasoMioranza, EleonoraDei Tos, Angelo PaoloConte, PierFrancoGuarneri, Valentina + ESMO OPEN - -
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 2023 Menichetti, AliceGriguolo, GaiaGiorgi, Carlo AlbertoGuarneri, ValentinaDieci, Maria Vittoria + NPJ BREAST CANCER - -